C004: Xgeva / Prolia Biosimilar Stable Cell Line (CHO)
The yield of Xgeva / Prolia biosimilar from the CHO stable cell line was above 9.0 g/L in a 15 liter manufacturing.
C004P: Denosumab Biosimilar, Human RANKL Monoclonal Antibody
Recombinant Humanized IgG2 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody denosumab biosimilar specifically binds to the human RANKL (RANK ligand) protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by denosumab.